These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 17287174)
1. Detection of tumor stem cell markers in pancreatic carcinoma cell lines. Olempska M; Eisenach PA; Ammerpohl O; Ungefroren H; Fandrich F; Kalthoff H Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):92-7. PubMed ID: 17287174 [TBL] [Abstract][Full Text] [Related]
2. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer. Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309 [TBL] [Abstract][Full Text] [Related]
3. The combination of stem cell markers CD133 and ABCG2 predicts relapse in stage I non-small cell lung carcinomas. Li F; Zeng H; Ying K Med Oncol; 2011 Dec; 28(4):1458-62. PubMed ID: 20717756 [TBL] [Abstract][Full Text] [Related]
4. Expressions of ABCG2, CD133, and podoplanin in salivary adenoid cystic carcinoma. Li W; Tamamura R; Wang B; Liu Q; Liu H; Liu T; Katase N; Xiao J; Nagatsuka H Biomed Res Int; 2014; 2014():132349. PubMed ID: 24804195 [TBL] [Abstract][Full Text] [Related]
5. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis. Kim N; Choung HK; Lee MJ; Khwarg SI; Kim JE Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1813-9. PubMed ID: 25711631 [TBL] [Abstract][Full Text] [Related]
6. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells. Jia Q; Zhang X; Deng T; Gao J Cell Reprogram; 2013 Apr; 15(2):143-50. PubMed ID: 23438193 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma. Hang D; Dong HC; Ning T; Dong B; Hou DL; Xu WG Dis Esophagus; 2012; 25(7):638-44. PubMed ID: 22236447 [TBL] [Abstract][Full Text] [Related]
8. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma. Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823 [TBL] [Abstract][Full Text] [Related]
9. Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines. Yao J; An Y; Wie JS; Ji ZL; Lu ZP; Wu JL; Jiang KR; Chen P; Xu ZK; Miao Y Swiss Med Wkly; 2011; 141():w13208. PubMed ID: 21630164 [TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus. Mahller YY; Williams JP; Baird WH; Mitton B; Grossheim J; Saeki Y; Cancelas JA; Ratner N; Cripe TP PLoS One; 2009; 4(1):e4235. PubMed ID: 19156211 [TBL] [Abstract][Full Text] [Related]
11. ABCG2 expression is correlated neither to side population nor to hematopoietic progenitor function in human umbilical cord blood. Alt R; Wilhelm F; Pelz-Ackermann O; Egger D; Niederwieser D; Cross M Exp Hematol; 2009 Feb; 37(2):294-301. PubMed ID: 19101070 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of circulating CD133(+) cells in patients with gastric cancer. Xia P; Song CL; Liu JF; Wang D; Xu XY Cell Prolif; 2015 Jun; 48(3):311-7. PubMed ID: 25727099 [TBL] [Abstract][Full Text] [Related]
13. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals. Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186 [TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells: lessons from melanoma. La Porta C Stem Cell Rev Rep; 2009 Mar; 5(1):61-5. PubMed ID: 19093230 [TBL] [Abstract][Full Text] [Related]
15. Detection and characterization of CD133+ cancer stem cells in human solid tumours. Tirino V; Desiderio V; d'Aquino R; De Francesco F; Pirozzi G; Graziano A; Galderisi U; Cavaliere C; De Rosa A; Papaccio G; Giordano A PLoS One; 2008; 3(10):e3469. PubMed ID: 18941626 [TBL] [Abstract][Full Text] [Related]
16. The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer. Herpel E; Jensen K; Muley T; Warth A; Schnabel PA; Meister M; Herth FJ; Dienemann H; Thomas M; Gottschling S Anticancer Res; 2011 Dec; 31(12):4491-500. PubMed ID: 22199321 [TBL] [Abstract][Full Text] [Related]
17. Chemoresistance of CD133+ cancer stem cells in laryngeal carcinoma. Yang JP; Liu Y; Zhong W; Yu D; Wen LJ; Jin CS Chin Med J (Engl); 2011 Apr; 124(7):1055-60. PubMed ID: 21542968 [TBL] [Abstract][Full Text] [Related]
18. Detection of CD133, Bmi-1, and ABCG2 in ameloblastic tumors. Kumamoto H; Ohki K J Oral Pathol Med; 2010 Jan; 39(1):87-93. PubMed ID: 19659474 [TBL] [Abstract][Full Text] [Related]
19. An isocorydine derivative (d-ICD) inhibits drug resistance by downregulating IGF2BP3 expression in hepatocellular carcinoma. Li M; Zhang L; Ge C; Chen L; Fang T; Li H; Tian H; Liu J; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J Oncotarget; 2015 Sep; 6(28):25149-60. PubMed ID: 26327240 [TBL] [Abstract][Full Text] [Related]
20. Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. Chen YC; Hsu HS; Chen YW; Tsai TH; How CK; Wang CY; Hung SC; Chang YL; Tsai ML; Lee YY; Ku HH; Chiou SH PLoS One; 2008 Jul; 3(7):e2637. PubMed ID: 18612434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]